Spinocerebellar Ataxia Type 1 (SCA1) Cell Models Display Widespread Mitochondrial and Extra-Nuclear Alterations

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Spinocerebellar Ataxia Type 1 (SCA1) is a neurodegenerative disease caused by expanded polyglutamine repeats in the Ataxin-1 (ATXN1) protein.
• While ATXN1's nuclear functions in transcription and splicing are known, its cytoplasmic role, particularly concerning mitochondria, is less understood.
• Previous studies linked mitochondrial dysfunction and oxidative stress to early SCA1 pathogenesis.

Purpose of the Study:

• To investigate the hypothesis that cytoplasmic ATXN1 interacts with mitochondria, contributing to mitochondrial dysfunction in SCA1.
• To characterize mitochondrial deficits caused by mutant ATXN1 in a cellular model.
• To explore the broader implications of ATXN1's compartmental functions in SCA1.

Main Methods:

• Utilized Daoy cells, a cerebellar cell line, as a model system.
• Created a SCA1 Daoy model overexpressing phosphorylation-prone ATXN1[82Q].
• Expressed a phosphorylation-resistant ATXN1 mutant (ATXN1[82Q-A776]) to assess specific effects.
• Performed meta-analysis of existing data on ATXN1 and mitochondrial protein interactions.

Main Results:

• Daoy SCA1 cells exhibited morphological, compositional, and physiological deficits.
• A modified ATXN1 mutant selectively altered physiological phenotypes and mitochondrial protein composition.
• Meta-analysis supported direct interactions between mutant ATXN1 and mitochondrial proteins involved in key cellular processes.
• Mitochondrial deficits were observed independently of nuclear aggregation or disease context.

Conclusions:

• Mutant ATXN1 contributes to mitochondrial dysfunction through cytoplasmic interactions, independent of its nuclear aggregation.
• ATXN1 influences cellular metabolic processes beyond its known nuclear roles.
• This study underscores the multifaceted and multicompartmental nature of ATXN1 function in health and disease.